Female-led stocks: Who rules the world?
34 No. of Symbols
0.49 USD
2.92 B USD
35.61 B USD
About GSK plc
Sector
Industry
CEO
Emma N. Walmsley
Website
Headquarters
London
ISIN
ARDEUT110483
FIGI
BBG003641Z45
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
GSK6023691
GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027Yield to maturity
—
Maturity date
Mar 12, 2027
GSK6023695
GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030Yield to maturity
—
Maturity date
Apr 15, 2030
GSK6023692
GlaxoSmithKline Capital Plc FRN 12-MAR-2027Yield to maturity
—
Maturity date
Mar 12, 2027
GSK6023693
GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035Yield to maturity
—
Maturity date
Apr 15, 2035
GSK3981911
GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043Yield to maturity
—
Maturity date
Mar 18, 2043
GSK.GJ
GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038Yield to maturity
—
Maturity date
May 15, 2038
XS293369143
GSK Capital BV 2.875% 19-NOV-2031Yield to maturity
—
Maturity date
Nov 19, 2031
XS182282812
GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026Yield to maturity
—
Maturity date
May 21, 2026
US377372AN7
GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028Yield to maturity
—
Maturity date
May 15, 2028
XS255381768
GSK Capital BV 3.0% 28-NOV-2027Yield to maturity
—
Maturity date
Nov 28, 2027
XS182282979
GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030Yield to maturity
—
Maturity date
May 21, 2030
See all GSKC bonds
Curated watchlists where GSKC is featured.
